Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume 109, Issue 2, Pages djw216
Publisher
Oxford University Press (OUP)
Online
2016-10-19
DOI
10.1093/jnci/djw216
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improving Care for Children With ADHD: The Information is Just a Rating Scale Away
- (2016) William J. Barbaresi PEDIATRICS
- Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice
- (2015) Jane J. Kim et al. ANNALS OF INTERNAL MEDICINE
- Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance
- (2015) Warner K. Huh et al. GYNECOLOGIC ONCOLOGY
- Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials
- (2015) Aimée R Kreimer et al. LANCET ONCOLOGY
- A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
- (2015) Elmar A. Joura et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012
- (2015) Susan Hariri et al. VACCINE
- National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2014
- (2015) Sarah Reagan-Steiner et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- An Updated Natural History Model of Cervical Cancer: Derivation of Model Parameters
- (2014) Nicole G. Campos et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Human Papillomavirus Genotype-Specific Prevalence across the Continuum of Cervical Neoplasia and Cancer
- (2014) N. E. Joste et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold
- (2014) Peter J. Neumann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine
- (2014) Paulo S Naud et al. Human Vaccines & Immunotherapeutics
- Screening for Cervical Cancer: U.S. Preventive Services Task Force Recommendation Statement
- (2013) Virginia A. Moyer ANNALS OF INTERNAL MEDICINE
- How distressing is referral to colposcopy in cervical cancer screening?
- (2013) Ida J. Korfage et al. GYNECOLOGIC ONCOLOGY
- Population Impact of HPV Vaccines: Summary of Early Evidence
- (2013) Susan Hariri et al. JOURNAL OF ADOLESCENT HEALTH
- 2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors
- (2013) L. Stewart Massad et al. Journal of Lower Genital Tract Disease
- American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
- (2012) Debbie Saslow et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A population-based study of human papillomavirus genotype prevalence in the United States: Baseline measures prior to mass human papillomavirus vaccination
- (2012) Cosette M. Wheeler et al. INTERNATIONAL JOURNAL OF CANCER
- Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine
- (2011) Aimée R. Kreimer et al. JNCI-Journal of the National Cancer Institute
- Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
- (2011) Julia ML Brotherton et al. LANCET
- Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection
- (2010) A. C. Rodriguez et al. JNCI-Journal of the National Cancer Institute
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 Vaccination
- (2008) J. D. Goldhaber-Fiebert et al. JNCI-Journal of the National Cancer Institute
- Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica
- (2008) Rolando Herrero et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now